OASIS-HT: design of a pharmacogenomic dose-finding study

Author： Staessen Jan A   Kuznetsova Tatiana   Acceto Rok   Bacchieri Antonella   Brand Eva   Burnier Michel   Celis Hilde   Citterio Lorena   de Leeuw Peter W   Filipovský Jan   Fournier Albert   Kawecka-Jaszcz Kalina   Manunta Paolo   Nikitin Yuri   O’Brien Eoin T   Redón Josep   Thijs Lutgarde   Ferrari Patrizia   Valentini Giovanni   Bianchi Giuseppe  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.7, 2005-10, pp. : 755-775

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

EMD 281014, a specific and potent 5HT2 antagonist in humans: a dose-finding PET study

By Mamo David   Sedman Ewen   Tillner Joachim   Sellers Edward   Romach Myroslava   Kapur Shitij  

Psychopharmacology, Vol. 175, Iss. 3, 2004-09 ,pp. : 382-388

Springer Publishing Company

Access to resources Recommend Favorite

Flexible Design and Efficient Implementation of Adaptive Dose-Finding Studies

By Weir Christopher  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1033-1050

Taylor & Francis Ltd

Access to resources Recommend Favorite

Design Issues in Dose-Finding Phase I Trials for Combinations of Two Agents

By Fan Shenghua Kelly  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 509-523

Taylor & Francis Ltd

Access to resources Recommend Favorite

Weekly Paclitaxel in Elderly Patients with Advanced Breast Cancer: A Dose-Finding Study

By Repetto L.  

Drugs in R&D, Vol. 5, Iss. 1, 2004-01 ,pp. : 11-15

Adis International

Access to resources Recommend Favorite

Flaws in Dose-Finding of Antihypertensive Drugs

By Stergiou George S.  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 5, 2007-01 ,pp. : 357-359

Adis International

Access to resources Recommend Favorite